Why the study?
Does lignocaine reduce ventricular arrhythmias in isolated perfused rat hearts subjected to coronary artery occlusion and reperfusion?
Does lignocaine reduce ventricular arrhythmias in isolated perfused rat hearts subjected to coronary artery occlusion and reperfusion?
Lignocaine demonstrates concentration-dependent antiarrhythmic effects against ischemia and reperfusion-induced ventricular arrhythmias in an isolated rat heart model.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open translation of lignocaine's antiarrhythmic effects to human reperfusion settings.
The isolated Langendorff-perfused rat heart, subjected to coronary artery occlusion and reperfusion consistently developed ventricular arrhythmias. The incidence of hearts with ventricular premature extrasystoles, ventricular tachycardia, and fibrillatioon ventricular fibrillation could be abolished in the presence of an extracellular potassium concentration of 12 mmol-litre--1, whereas with 4.5 mmol-litre--1 all hearts developed all the ventricular arrhythmias including fibrillation. This predictable occurrence of ventricular arrhythmias was used to assess the antiarrhythmic effect of lignocaine with particular reference to its effect on the spontaneously occurring reperfusion ventricular fibrillation. Lignocaine decreased the incidence of all ventricular arrhythmias both during ischaemia and on reperfusion in a concentration-related fashion.
No takes yet. Share an insight, caveat, or question.
Lubbe et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: